ABCA1 and neoplasm: A cholesterol-lowering drug, simvastatin, was able to repolarize tumor-associated macrophages (TAM), promoting the M2-to-M1 phenotype switch via cholesterol-associated liver X receptor (LXR)/ATP-binding cassette transporter A1 (ABCA1) regulation [91].